These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21700759)

  • 1. Use of non-invasive haemodynamic measurements to detect treatment response in precapillary pulmonary hypertension.
    Lee WT; Brown A; Peacock AJ; Johnson MK
    Thorax; 2011 Sep; 66(9):810-4. PubMed ID: 21700759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.
    Andreassen AK; Wergeland R; Simonsen S; Geiran O; Guevara C; Ueland T
    Am J Cardiol; 2006 Aug; 98(4):525-9. PubMed ID: 16893710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive cardiac output measurement by inert gas rebreathing in suspected pulmonary hypertension.
    Farina S; Teruzzi G; Cattadori G; Ferrari C; De Martini S; Bussotti M; Calligaris G; Bartorelli A; Agostoni P
    Am J Cardiol; 2014 Feb; 113(3):546-51. PubMed ID: 24315114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Submaximal exercise testing may be superior to the 6-min walk test in assessing pulmonary arterial hypertension disease severity.
    Neal JE; Lee AS; Burger CD
    Clin Respir J; 2014 Oct; 8(4):404-9. PubMed ID: 24308300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise testing to estimate survival in pulmonary hypertension.
    Groepenhoff H; Vonk-Noordegraaf A; Boonstra A; Spreeuwenberg MD; Postmus PE; Bogaard HJ
    Med Sci Sports Exerc; 2008 Oct; 40(10):1725-32. PubMed ID: 18799981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
    Reesink HJ; van der Plas MN; Verhey NE; van Steenwijk RP; Kloek JJ; Bresser P
    J Thorac Cardiovasc Surg; 2007 Feb; 133(2):510-6. PubMed ID: 17258590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise performance in patients with pulmonary hypertension linked to cardiac magnetic resonance measures.
    Stevens GR; Lala A; Sanz J; Garcia MJ; Fuster V; Pinney S
    J Heart Lung Transplant; 2009 Sep; 28(9):899-905. PubMed ID: 19716042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term recovery of exercise ability after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
    Matsuda H; Ogino H; Minatoya K; Sasaki H; Nakanishi N; Kyotani S; Kobayashi J; Yagihara T; Kitamura S
    Ann Thorac Surg; 2006 Oct; 82(4):1338-43; discussion 1343. PubMed ID: 16996930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke volume increase to exercise in chronic obstructive pulmonary disease is limited by increased pulmonary artery pressure.
    Holverda S; Rietema H; Westerhof N; Marcus JT; Gan CT; Postmus PE; Vonk-Noordegraaf A
    Heart; 2009 Feb; 95(2):137-41. PubMed ID: 18474537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension.
    Torbicki A; Kurzyna M; Kuca P; Fijałkowska A; Sikora J; Florczyk M; Pruszczyk P; Burakowski J; Wawrzyńska L
    Circulation; 2003 Aug; 108(7):844-8. PubMed ID: 12900346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive assessment of pulmonary blood flow using an inert gas rebreathing device in fibrotic lung disease.
    Corte TJ; Wells AU; Gatzoulis MA; Cramer D; Ward S; Macdonald PS; Dimopoulos K; Wort SJ
    Thorax; 2010 Apr; 65(4):341-5. PubMed ID: 20388760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerobic exercise capacity in COPD patients with and without pulmonary hypertension.
    Pynnaert C; Lamotte M; Naeije R
    Respir Med; 2010 Jan; 104(1):121-6. PubMed ID: 19577458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive stroke volume measurement by cardiac magnetic resonance imaging and inert gas rebreathing in pulmonary hypertension.
    McLure LE; Brown A; Lee WN; Church AC; Peacock AJ; Johnson MK
    Clin Physiol Funct Imaging; 2011 May; 31(3):221-6. PubMed ID: 21470362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic hyperinflation during exercise in patients with precapillary pulmonary hypertension.
    Richter MJ; Voswinckel R; Tiede H; Schulz R; Tanislav C; Feustel A; Morty RE; Ghofrani HA; Seeger W; Reichenberger F
    Respir Med; 2012 Feb; 106(2):308-13. PubMed ID: 22100539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous hemodynamic monitoring in patients with pulmonary arterial hypertension.
    Frantz RP; Benza RL; Kjellström B; Bourge RC; Barst RJ; Bennett TD; McGoon MD
    J Heart Lung Transplant; 2008 Jul; 27(7):780-8. PubMed ID: 18582809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of pulmonary hemodynamics on 6-min walk test in idiopathic pulmonary fibrosis.
    Minai OA; Santacruz JF; Alster JM; Budev MM; McCarthy K
    Respir Med; 2012 Nov; 106(11):1613-21. PubMed ID: 22902266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease.
    Holland AE; Hill CJ; Rasekaba T; Lee A; Naughton MT; McDonald CF
    Arch Phys Med Rehabil; 2010 Feb; 91(2):221-5. PubMed ID: 20159125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement properties of the 6-min walk test in individuals with exercise-induced pulmonary arterial hypertension.
    Fowler RM; Jenkins SC; Maiorana AJ; Gain KR; O'Driscoll G; Gabbay E
    Intern Med J; 2011 Sep; 41(9):679-87. PubMed ID: 21470356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy: the impact of late referral.
    Badagliacca R; Pezzuto B; Poscia R; Mancone M; Papa S; Marcon S; Valli G; Sardella G; Ferrante F; Iacoboni C; Parola D; Fedele F; Vizza CD
    J Heart Lung Transplant; 2012 Apr; 31(4):364-72. PubMed ID: 22289484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.